"Chemobrain" impairment may be result of cancer, not drugs

The forgetfulness and other types of mild mental impairment suffered by some cancer patients -- sometimes called "chemobrain" -- may not be linked to potent anti-cancer drugs, as has been suspected, but instead may be caused by the cancer itself, a new study says. Out of 84 breast cancer patients diagnosed with neurological problems, 35% reported having cognitive problems prior to receiving chemotherapy drugs, and it represents the first time researchers have documented such problems before chemotherapy.

View Full Article in:

Cincinnati Enquirer (tiered subscription model), The

Published in Brief:

SmartBrief Job Listings for Health Care